ANXA2 and renal cell carcinoma: The 5-years metastasis-free rate in patients with ANXA2-positive RCC was significantly lower than those with ANXA2-negative RCC, indicating that ANXA2 may be a predictor for metastasis and a useful marker for prognosis.